Cancer Chemo Pharm Flashcards
Cisplatin
MOA: cross-linking of DNA
Use: testicular, bladder, lung, colon, ovarian CA
Dose Limiting Tox (DLT): peripheral neuropathy
SAE: ototoxicity, myelosuppression
Cyclophosphamide
MOA: alkylation and cross linking of DNA
Uses: leukemias, lymphomas, solid tumors
DLT: myelosuppression
SAE: hemorrhagic cystitis
Cytarabine
MOA: inhibitor of DNA polymerase, misincorporation into DNA
Uses: leukemias, lymphomas
DLT: myelosuppression
Fluorouracil
MOA: activated to FdUMP which inhibits thymidylate synthetase, also misincorporated into RNA
Uses: colon CA, many solid tumors
DLT: myelosuppression
SAE: GI toxicity
Hydroxyurea
MOA: inhibitor of ribonucleotide reductase which is required to convert ribonucleotides to deoxyribonucleotides
USes: melanoma, CML
DLT: myelosuppressionn
SAE: GI toxicity
Methotrexate
MOA: DHFR inhibitor
Uses: ALL, choriocarcinoma, lymphomas, many solid tumors
DLT: myelosuppression
Thioguanine
MOA: inhibitor of purine metabolism
Uses: acute leukemias, chronic myelocytic leukemia
DLT: myelosupression
Bleomycin
MOA: interacts with DNA and catalyzes free radical formation and DNA destruction Uses: Hodgkin's lymphoma, testicular CA DLT: Pulmonary fibrosis SAE: radiation recall, skin lesions
Bevacizumab
MOA: antibody against VEGF, inhibits angiogenesis
Uses: epithelial cancers in combo with std therapy
SAE: vascular toxicity ( stroke or MI)
Cetuximab
MOA: monoclonal antibody against the extracellular domain of EGFR
Uses: colon cancer, head/neck tumors
SAE: skin lesion
Crizotinib
MOA: ALK inhibitor
Uses: non-small lung CA
SAE: bradycardia, visual disturbances
Erlotinib
MOA: EGFR inhibitor
Uses: colon CA
SAE: skin lesions
Imatinib
MOA: inibitor of ABL, Kit, PDGF-R tyrosine kinases
Uses: CML, GIST
SAE: fluid retension, some myelosuppression
Rituximab
MOA: binds to CD20 on the surface of B cells and leads to antibody dependent cellular cytotoxicity
Uses: non-Hodgkin’s lymphoma, B cell leukemias
DLT: myelosuppression
SAE: sensitivity reactions
Sunitinib
MOA: inhibitor of RTKs including VEGF-R, PDGF-R, cKit
Uses: inhibits angiogensis and some growth factor dependent tumors, renal cell carcinoma
SAE: vascular toxicity